docruДоктор.РуTitle1727-23782713-2994ООО "ГК "РУСМЕДИКАЛ"10.31550/1727-2378-2023-22-2-70-75docru-239Research ArticleПУЛЬМОНОЛОГИЯPULMONOLOGYРеспираторная реабилитация пациентов с COVID-19: текущее состояние проблемыRespiratory Rehabilitation of COVID-19 Patients: Current State of the Problemhttps://orcid.org/0000-0002-6116-1292ПетровК. В.PetrovK. V.

Петров Кирилл Владимирович — аспирант кафедры физической и реабилитационной медицины с курсом ПО ФГБОУ ВО КрасГМУ им. проф. В.Ф. Войно-Ясенецкого Минздрава России.

660022, Красноярск, ул. Партизана Железняка, д. 1

1 Partizan Zheleznyak St., Krasnoyarsk, 660022

kllpetrov@mail.ruhttps://orcid.org/0000-0002-9412-1529МожейкоЕ. Ю.MozheykoE. Yu.

Можейко Елена Юрьевна — д. м. н., доцент, заведующая кафедрой физической и реабилитационной медицины с курсом ПО ФГБОУ ВО КрасГМУ им. проф. В.Ф. Войно-Ясенецкого Минздрава России.

660022, Красноярск, ул. Партизана Железняка, д. 1

1 Partizan Zheleznyak St., Krasnoyarsk, 660022

el_mozhejko@mail.ruhttps://orcid.org/0000-0003-2757-4875ПетровА. В.PetrovA. V.

Петров Артём Владимирович — студент 4-го курса лечебного факультета ФГБОУ ВО КрасГМУ им. проф. В.Ф. Войно-Ясенецкого Минздрава России.

660022, Красноярск, ул. Партизана Железняка, д. 1

1 Partizan Zheleznyak St., Krasnoyarsk, 660022

https://orcid.org/0000-0001-8982-5292ДемкоИ. В.DemkoI. V.

Демко Ирина Владимировна — д. м. н., профессор, заведующая кафедрой госпитальной терапии и иммунологии с курсом ПО ФГБОУ ВО КрасГМУ им. проф. В.Ф. Войно-Ясенецкого Минздрава России.

660022, Красноярск, ул. Партизана Железняка, д. 1

1 Partizan Zheleznyak St., Krasnoyarsk, 660022

demko64@mail.ruФГБОУ ВО «Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого» Минздрава РоссииРоссияProfessor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical UniversityRussian Federation202318022025222ТЕРАПИЯ7075Copyright © Петров К.В., Можейко Е.Ю., Петров А.В., Демко И.В., 20252025Петров К.В., Можейко Е.Ю., Петров А.В., Демко И.В.Petrov K.V., Mozheyko E.Y., Petrov A.V., Demko I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://docru.elpub.ru/jour/article/view/239Цель

Цель: обобщить данные литературы по респираторной реабилитации у пациентов с новой коронавирусной инфекцией, оценить текущее состояние проблемы и перспективы ее решения.

Основные положения

Основные положения. Новая коронавирусная инфекция (COVID-19) — это высококонтагиозное острое респираторное инфекционное заболевание с первичным поражением верхних и нижних дыхательных путей, органов и систем организма человека. Проявления заболевания широко варьируются от бессимптомного носительства до клинически тяжелой формы вирусной пневмонии, требующей кислородной терапии и респираторной поддержки. Респираторная реабилитация играет жизненно важную роль в выздоровлении пациентов. В мире идет накопление базы данных и профессиональной информации о респираторной реабилитации пациентов с COVID-19, т.к. общепринятые методы реабилитации после респираторных заболеваний могут быть неэффективными или небезопасными.

Заключение

Заключение. Респираторную реабилитацию следует проводить на протяжении всего процесса лечения COVID-19, начиная в условиях отделений реанимации и интенсивной терапии при стабильном состоянии пациента. Реабилитационные мероприятия должны быть персонализированными. Будущие исследования должны помочь понять траекторию движения развития легочной реабилитации с целью улучшения качества жизни пациентов и скорейшего восстановления их активности.

Objective of the Review

Objective of the Review: To summarise the data from literature sources on respiratory rehabilitation of patients with the novel coronavirus infection; to assess the current state and perspectives.

Key Points

Key Points. The novel coronavirus infection (COVID-19) is a highly contagious acute respiratory disease with primary involvement of upper and lower respiratory tract, organs and systems of the body. The symptoms of the disease vary from asymptomatic carrier to clinically severe viral pneumonia that requires oxygen therapy and respiratory support. Respiratory rehabilitation is vital for patient recovery. Globally, there is more and more professional information and databases on respiratory rehabilitation of COVID-19 patients, since the common methods of rehabilitation after a respiratory disease can be ineffective or unsafe.

Conclusion

Conclusion. Respiratory rehabilitation should be an integral part of COVID-19 therapy, starting from ICU once the patient’s condition has stabilised. Rehabilitation should be personalised. Future studies will help in understanding the development path of pulmonary rehabilitation in order to improve the quality of patients’ life and to facilitate faster activity restoration.

реабилитацияреспираторная реабилитациякоронавирусная инфекцияCOVID-19дыхательные упражненияrehabilitationrespiratory rehabilitationcoronavirus infectionCOVID-19breathing exercisesReferencesBrugliera L., Spina A., Castellazzi P. et al. Rehabilitation of COVID-19 patients. J. Rehabil. Med. 2020;52(4):jrm00046. DOI: 10.2340/16501977-2678Brugliera L., Spina A., Castellazzi P. et al. Rehabilitation of COVID-19 patients. J. Rehabil. Med. 2020;52(4):jrm00046. DOI: 10.2340/16501977-2678Бубнова М.Г., Шляхто Е.В., Аронов Д.М. и др. Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации. Российский кардиологический журнал. 2021;26(5):4487. DOI: 10.15829/1560-4071-2021-4487Bubnova M.G., Shlyakhto E.V., Aronov D.M. et al. Coronavirus disease 2019: features of comprehensive cardiac and pulmonary rehabilitation. Russian Journal of Cardiology. 2021;26(5):4487. (in Russian). DOI: 10.15829/1560-4071-2021-4487Кабыш С.С., Карпенкова А.Д., Прокопенко С.В. Когнитивные нарушения и COVID-19. Сибирское медицинское обозрение. 2022;(2):40–48. DOI: 10.20333/25000136-2022-2-40-48Kabysh S.S., Karpenkova A.D., Prokopenko S.V. Cognitive impairments and COVID-19. Siberian Medical Review. 2022;(2):40–48. (in Russian). DOI: 10.20333/25000136-2022-2-40-48Ма-Ван-дэ В.Д., Зайцев Д.Н., Филев А.П. и др. Клинико-лабораторные маркеры тяжести течения новой коронавирусной инфекции (COVID-19). Сибирское медицинское обозрение. 2022;(3):40–48. DOI: 10.20333/25000136-2022-3-40-48Ma-Van-de V.D., Zaitsev D.N., Filev A.P. et al. Clinical and laboratory markers of severity of the new coronavirus infection (COVID-19). Siberian Medical Review. 2022;(3):40–48. (in Russian). DOI: 10.20333/25000136-2022-3-40-48Forchette L., Sebastian W., Liu T. A Comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics. Curr. Med. Sci. 2021;41(6):1037–1051. DOI: 10.1007/s11596-021-2395-1Forchette L., Sebastian W., Liu T. A Comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics. Curr. Med. Sci. 2021;41(6):1037–1051. DOI: 10.1007/s11596-021-2395-1Davies N.G., Abbott S., Barnard R.C. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055. DOI: 10.1126/science.abg3055Davies N.G., Abbott S., Barnard R.C. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055. DOI: 10.1126/science.abg3055Leung K., Shum M.H., Leung G.M. et al. Early transmissibility assessment of the n501y mutant strains of sars-cov-2 in the United Kingdom, October to November 2020. EuroSurveill.2021;26:2002106. DOI: 10.2807/1560-7917.ES.2020.26.1.2002106Leung K., Shum M.H., Leung G.M. et al. Early transmissibility assessment of the n501y mutant strains of sars-cov-2 in the United Kingdom, October to November 2020. EuroSurveill.2021;26:2002106. DOI: 10.2807/1560-7917.ES.2020.26.1.2002106Volz E., Mishra S., Chand M. et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 2021;593(7858):266–269. DOI: 10.1038/s41586-021-03470-xVolz E., Mishra S., Chand M. et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 2021;593(7858):266–269. DOI: 10.1038/s41586-021-03470-xPublic-Health-England. Investigation of novel SARS-CoV-2 variants of concern. (2021). URL: https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201Public-Health-England. Investigation of novel SARS-CoV-2 variants of concern. (2021). URL: https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201Pearson C.A.B., Russell T.W., Davies N., Kucharski A.J. Estimates of severity and transmissibility of novel South Africa SARS-CoV-2 Variant 501Y.V2 (2021). URL: https://cmmidgithubio/topics/covid19/sa-novel-variant.htmlPearson C.A.B., Russell T.W., Davies N., Kucharski A.J. Estimates of severity and transmissibility of novel South Africa SARS-CoV-2 Variant 501Y.V2 (2021). URL: https://cmmidgithubio/topics/covid19/sa-novel-variant.htmlVolz E., Hill V., McCrone J.T., Price A. et. al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184(1):64–75.e11. DOI: 10.1016/j.cell.2020.11.020Volz E., Hill V., McCrone J.T., Price A. et. al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184(1):64–75.e11. DOI: 10.1016/j.cell.2020.11.020Wang P., Casner R.G., Nair M.S. et al. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. bioRxiv [Preprint]. 2021: 2021.03.01.433466. DOI: 10.1101/2021.03.01.433466Wang P., Casner R.G., Nair M.S. et al. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. bioRxiv [Preprint]. 2021: 2021.03.01.433466. DOI: 10.1101/2021.03.01.433466Campbell F., Archer B., Laurenson-Schafer H. et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill. 2021;26(24):2100509. DOI: 10.2807/1560-7917.ES.2021.26.24.2100509Campbell F., Archer B., Laurenson-Schafer H. et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill. 2021;26(24):2100509. DOI: 10.2807/1560-7917.ES.2021.26.24.2100509SARS-CoV-2 Variants of concern and variants under investigation in England (2021). URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001358/Variants_of_Concern_VOC_Technical_Briefing_18.pdfSARS-CoV-2 Variants of concern and variants under investigation in England (2021). URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001358/Variants_of_Concern_VOC_Technical_Briefing_18.pdfSheikh A., McMenamin J., Taylor B., Robertson C. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397(10293):2461–2462. DOI: 10.1016/S0140-6736(21)01358-1Sheikh A., McMenamin J., Taylor B., Robertson C. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397(10293):2461–2462. DOI: 10.1016/S0140-6736(21)01358-1Khedar R.S., Mittal K., Ambaliya H.C. et al. Greater COVID-19 severity and mortality in hospitalized patients in second (Delta Variant) wave compared to the first: single centre prospective study in India. medRxiv. 2021; 2021.09.03.21263091. DOI: 10.1101/2021.09.03.21263091Khedar R.S., Mittal K., Ambaliya H.C. et al. Greater COVID-19 severity and mortality in hospitalized patients in second (Delta Variant) wave compared to the first: single centre prospective study in India. medRxiv. 2021; 2021.09.03.21263091. DOI: 10.1101/2021.09.03.21263091Sheikhzadegan S., Alaghemand N., Fox M., Venkataraman V. Analysis of the delta variant B.1.617.2 COVID-19. Clin. Pract. 2021;11(4):778–784. DOI: 10.3390/clinpract11040093Sheikhzadegan S., Alaghemand N., Fox M., Venkataraman V. Analysis of the delta variant B.1.617.2 COVID-19. Clin. Pract. 2021;11(4):778–784. DOI: 10.3390/clinpract11040093Araf Y., Akter F., Tang Y.D. et al. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. J. Med. Virol. 2022;94(5):1825–1832. DOI: 10.1002/jmv.27588/Araf Y., Akter F., Tang Y.D. et al. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. J. Med. Virol. 2022;94(5):1825–1832. DOI: 10.1002/jmv.27588/Vaporidi K., Akoumianaki E., Telias I. et al. Respiratory drive in critically ill patients. Pathophysiology and clinical implications. Am. J. Respir. Crit. Care Med. 2020;201(1):20–32. DOI: 10.1164/rccm.201903-0596SOVaporidi K., Akoumianaki E., Telias I. et al. Respiratory drive in critically ill patients. Pathophysiology and clinical implications. Am. J. Respir. Crit. Care Med. 2020;201(1):20–32. DOI: 10.1164/rccm.201903-0596SOManning H.L., Schwartzstein R.M. Pathophysiology of dyspnea. N. Engl. J. Med. 1995;333(23):1547–1553. DOI: 10.1056/NEJM199512073332307Manning H.L., Schwartzstein R.M. Pathophysiology of dyspnea. N. Engl. J. Med. 1995;333(23):1547–1553. DOI: 10.1056/NEJM199512073332307Torres-Torrelo H., Ortega-Sáenz P., Gao L., López-Barneo J. Lactate sensing mechanisms in arterial chemoreceptor cells. Nat. Commun. 2021;12(1):4166. DOI: 10.1038/s41467-021-24444-7Torres-Torrelo H., Ortega-Sáenz P., Gao L., López-Barneo J. Lactate sensing mechanisms in arterial chemoreceptor cells. Nat. Commun. 2021;12(1):4166. DOI: 10.1038/s41467-021-24444-7Dhont S., Derom E., Van Braeckel E. et al. The pathophysiology of 'happy' hypoxemia in COVID-19. Respir. Res. 2020;21(1):198. DOI: 10.1186/s12931-020-01462-5Dhont S., Derom E., Van Braeckel E. et al. The pathophysiology of 'happy' hypoxemia in COVID-19. Respir. Res. 2020;21(1):198. DOI: 10.1186/s12931-020-01462-5Lippi G., Henry B.M. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir. Med. 2020;167:105941. DOI: 10.1016/j.rmed.2020.105941Lippi G., Henry B.M. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir. Med. 2020;167:105941. DOI: 10.1016/j.rmed.2020.105941Pericàs J.M., Hernandez-Meneses M., Sheahan T.P. et al. COVID-19: from epidemiology to treatment. Eur. Heart J. 2020;41(22):2092–2112. DOI: 10.1093/eurheartj/ehaa462Pericàs J.M., Hernandez-Meneses M., Sheahan T.P. et al. COVID-19: from epidemiology to treatment. Eur. Heart J. 2020;41(22):2092–2112. DOI: 10.1093/eurheartj/ehaa462Wu C., Chen X., Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180(7):934–943. DOI: 10.1001/jamainternmed.2020.0994Wu C., Chen X., Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180(7):934–943. DOI: 10.1001/jamainternmed.2020.0994Parohan M., Yaghoubi S., Seraji A. et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416–1424. DOI: 10.1080/13685538.2020.1774748Parohan M., Yaghoubi S., Seraji A. et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416–1424. DOI: 10.1080/13685538.2020.1774748Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 6 (28.04.2020)». 18 c. URL: https://static1.rosminzdrav.ru/system/attachments/attaches/000/050/122/original/28042020_%D0%9CR_COVID-19_v6.pdfInterim guidelines “Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19). Version 6 (28.04.2020)». 18 p. (in Russian). URL: https://static1.rosminzdrav.ru/system/attachments/attaches/000/050/122/original/28042020_%D0%9CR_COVID-19_v6.pdfSiddiq M.A.B., Rathore F.A., Clegg D., Rasker J.J. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic. Turk. J. Phys. Med. Rehabil. 2020;66(4):480–494. DOI: 10.5606/tftrd.2020.6889Siddiq M.A.B., Rathore F.A., Clegg D., Rasker J.J. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic. Turk. J. Phys. Med. Rehabil. 2020;66(4):480–494. DOI: 10.5606/tftrd.2020.6889Spruit M.A., Singh S.J., Garvey C. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013; 188(8): e13–e64. DOI: 10.1164/rccm.201309-1634STSpruit M.A., Singh S.J., Garvey C. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013; 188(8): e13–e64. DOI: 10.1164/rccm.201309-1634STYang X., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8(5):475–481. DOI: 10.1016/S2213-2600(20)30079-5Yang X., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8(5):475–481. DOI: 10.1016/S2213-2600(20)30079-5Levy J., Léotard A., Lawrence C. et.al. A model for a ventilator-weaning and early rehabilitation unit to deal with post-ICU impairments following severe COVID-19. Ann. Phys. Rehabil. Med. 2020;63(4):376–378. DOI: 10.1016/j.rehab.2020.04.002Levy J., Léotard A., Lawrence C. et.al. A model for a ventilator-weaning and early rehabilitation unit to deal with post-ICU impairments following severe COVID-19. Ann. Phys. Rehabil. Med. 2020;63(4):376–378. DOI: 10.1016/j.rehab.2020.04.002Simpson R., Robinson L. Rehabilitation following critical illness in people with COVID-19 infection. Am. J. Phys. Med. Rehabil. 2020; 10.1097/PHM.0000000000001443. DOI: 10.1097/PHM.0000000000001443Simpson R., Robinson L. Rehabilitation following critical illness in people with COVID-19 infection. Am. J. Phys. Med. Rehabil. 2020; 10.1097/PHM.0000000000001443. DOI: 10.1097/PHM.0000000000001443Thomas P., Baldwin C., Bissett B., Boden I. et. al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J. Physiother. 2020;66(2):73–82. DOI: 10.1016/j.jphys.2020.03.011Thomas P., Baldwin C., Bissett B., Boden I. et. al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J. Physiother. 2020;66(2):73–82. DOI: 10.1016/j.jphys.2020.03.011Wang T.J., Chau B., Lui M. et al. Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am. J. Phys. Med. Rehabil. 2020;99(9):769–774. DOI: 10.1097/PHM.0000000000001505Wang T.J., Chau B., Lui M. et al. Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am. J. Phys. Med. Rehabil. 2020;99(9):769–774. DOI: 10.1097/PHM.0000000000001505Yang F., Liu N., Hu J.Y. et al. Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV). Zhonghua Jie He He Hu Xi Za Zhi. 2020.12;43(3):180–182. DOI: 10.3760/cma.j.issn.1001-0939.2020.03.007Yang F., Liu N., Hu J.Y. et al. Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV). Zhonghua Jie He He Hu Xi Za Zhi. 2020.12;43(3):180–182. DOI: 10.3760/cma.j.issn.1001-0939.2020.03.007Fink J.B. Positioning versus postural drainage. Respir. Care. 2002;47(7):769–777.Fink J.B. Positioning versus postural drainage. Respir. Care. 2002;47(7):769–777.Cullen D.L., Rodak B. Clinical utility of measures of breathlessness. Respir. Care. 2002;47(9):986–993.Cullen D.L., Rodak B. Clinical utility of measures of breathlessness. Respir. Care. 2002;47(9):986–993.Gautam A.P., Arena R., Dixit S., Borghi-Silva A. Pulmonary rehabilitation in COVID-19 pandemic era: The need for a revised approach. Respirology. 2020;25(12):1320–1322. DOI: 10.1111/resp.13946Gautam A.P., Arena R., Dixit S., Borghi-Silva A. Pulmonary rehabilitation in COVID-19 pandemic era: The need for a revised approach. Respirology. 2020;25(12):1320–1322. DOI: 10.1111/resp.13946Parry S.M., Knight L.D., Connolly B. et. al. Factors influencing physical activity and rehabilitation in survivors of critical illness: a systematic review of quantitative and qualitative studies. Intensive Care Med. 2017;43(4):531–542. DOI: 10.1007/s00134-017-4685-4Parry S.M., Knight L.D., Connolly B. et. al. Factors influencing physical activity and rehabilitation in survivors of critical illness: a systematic review of quantitative and qualitative studies. Intensive Care Med. 2017;43(4):531–542. DOI: 10.1007/s00134-017-4685-4Временные методические рекомендации «Медицинская реабилитация при новой коронавирусной инфекции (COVID-19). Версия 2 (31.07.2020)». 151 с. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdfTemporary guidelines «Medical rehabilitation for a new coronavirus infection (COVID-19). Version 2 (31.07.2020)». 151 p. (in Russian). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdfZhao H.M., Xie Y.X., Wang C et al. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin. Med. J. (Engl.). 2020;133(13):1595–1602. DOI: 10.1097/CM9.0000000000000848Zhao H.M., Xie Y.X., Wang C et al. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin. Med. J. (Engl.). 2020;133(13):1595–1602. DOI: 10.1097/CM9.0000000000000848Grigoletto I., Cavalheri V., Lima F.F., Ramos E.M.C. Recovery after COVID-19: The potential role of pulmonary rehabilitation. Braz. J. Phys. Ther. 2020;24(6):463–464. DOI: 10.1016/j.bjpt.2020.07.002Grigoletto I., Cavalheri V., Lima F.F., Ramos E.M.C. Recovery after COVID-19: The potential role of pulmonary rehabilitation. Braz. J. Phys. Ther. 2020;24(6):463–464. DOI: 10.1016/j.bjpt.2020.07.002Barazzoni R., Bischoff S.C., Breda J. et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin. Nutr. 2020;39(6):1631–1638. DOI: 10.1016/j.clnu.2020.03.022Barazzoni R., Bischoff S.C., Breda J. et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin. Nutr. 2020;39(6):1631–1638. DOI: 10.1016/j.clnu.2020.03.022Carfì A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. DOI: 10.1001/jama.2020.12603Carfì A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. DOI: 10.1001/jama.2020.12603Khan F., Amatya B. Medical rehabilitation in pandemics: towards a new perspective. J. Rehabil. Med. 2020;52(4):jrm00043. DOI: 10.2340/16501977-2676Khan F., Amatya B. Medical rehabilitation in pandemics: towards a new perspective. J. Rehabil. Med. 2020;52(4):jrm00043. DOI: 10.2340/16501977-2676Ambrosino N., Fracchia C. The role of tele-medicine in patients with respiratory diseases. Expert Rev. Respir. Med. 2017;11(11):893–900. DOI: 10.1080/17476348.2017.1383898Ambrosino N., Fracchia C. The role of tele-medicine in patients with respiratory diseases. Expert Rev. Respir. Med. 2017;11(11):893–900. DOI: 10.1080/17476348.2017.1383898Yang L.L., Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis. Transl. Med. 2020;6(2):79–86. DOI: 10.1016/j.cdtm.2020.05.002Yang L.L., Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis. Transl. Med. 2020;6(2):79–86. DOI: 10.1016/j.cdtm.2020.05.002Liu K., Zhang W., Yang Y. et al. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther. Clin. Pract. 2020;39:101166. DOI: 10.1016/j.ctcp.2020.101166Liu K., Zhang W., Yang Y. et al. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther. Clin. Pract. 2020;39:101166. DOI: 10.1016/j.ctcp.2020.101166Donner C.F., Raskin J., ZuWallack R. et al. Incorporating telemedicine into the integrated care of the COPD patient a summary of an interdisciplinary workshop held in Stresa, Italy, 7-8 September 2017. Respir. Med. 2018;143:91–102. DOI: 10.1016/j.rmed.2018.09.003Donner C.F., Raskin J., ZuWallack R. et al. Incorporating telemedicine into the integrated care of the COPD patient a summary of an interdisciplinary workshop held in Stresa, Italy, 7-8 September 2017. Respir. Med. 2018;143:91–102. DOI: 10.1016/j.rmed.2018.09.003Bartlo P., Bauer N. Pulmonary rehabilitation post-acute care for COVID-19 (PACER). URL: https://youtu.be/XjY_7O3Qpd8 (data of access: 11.05.2020).Bartlo P., Bauer N. Pulmonary rehabilitation post-acute care for COVID-19 (PACER). URL: https://youtu.be/XjY_7O3Qpd8 (data of access: 11.05.2020).

The authors declare that there are no conflicts of interest present.